Publications – Cellus Group

2015. Front Immunol. Role of Dendritic Cells in the Induction of Lymphocyte Tolerance.
2015. Br J Cancer. Overexpression of connexin 43 reduces melanoma proliferative and metastatic capacity.
2014. Hum Vaccin Immunother. Tumor cell lysates as immunogenic sources for cancer vaccine design.
2014. Immunology. Melanoma cell lysate induces CCR7 expression and in vivo migration to draining lymph nodes of therapeutic human dendritic cells.
2014. Immunobiology. Melanocortin 1 Receptor-derived peptides are efficiently recognized by cytotoxic T lymphocytes from melanoma patients.
2014. The Journal of Immunology. Gap Junction Intercellular Communications Regulate NK Cell Activation and Modulate NK Cytotoxic Capacity.
2013. Biol Res. TapCells®, the Chilean dendritic cell vaccine against melanoma and prostate cancer.
2013. Cancer Immunol Immunother.The immunological response and post-treatment survival of DC-vaccinated melanoma patients are associated with increased Th1/Th17 and reduced Th3 cytokine responses.
2013. Cancer Immunol Immunother. Immunological and Clinical Outcomes of DC-Vaccinated Melanoma Patients Are Associated with Increased Th1/Th17 and Reduced Th3 Cytokine Responses.
2013. British Journal of Cancer. Tumour cell lysate-loaded dendritic cell vaccine induces biochemical and memory immune response in castration-resistant prostate cancer patients.
2013. Biological Research. TapCells®, the Chilean dendritic cell vaccine against melanoma and prostate cancer.
2012. Cancer Immunol Immunother. Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients.
2011. Clinical Cancer Research. Heat-Shock Induction of Tumor-Derived Danger Signals Mediate Rapid Monocyte Differentiation into Clinically Effective Dendritic Cells.
2009. Journal Of Clinical Oncology. Prolonged Survival of Dendritic Cell–Vaccinated Melanoma Patients Correlates With Tumor-Specific Delayed Type IV Hypersensitivity Response and Reduction of Tumor Growth Factor B-Expressing T Cells.
2007. Cytokine Growth Factor. Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape.
2006. Immunolobiology. The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines.
2005. Clinical And Experimental Immunology. Dendritic cell immunizations alone or combined with low doses of interleukin-2 induce specific immune responses in melanoma